Naltrexone Walter Ritter (Naltrexone Hydrochloride)

Naltrexone competitively blocks mu, kappa, and delta opioid receptors in the central nervous system. By occupying these receptors without activating them, it prevents both endogenous opioids and exogenous opioid drugs from binding, thereby diminishing the reinforcing and euphoric effects that contribute to alcohol and opioid use.

The specific dosage and regimen of Naltrexone Walter Ritter are determined by the prescribing healthcare professional based on the individual’s medical condition, response to therapy, and other clinical factors. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

The safety of naltrexone in pregnancy and lactation has not been definitively established. It is classified as pregnancy category unknown, and clinicians should weigh potential benefits against possible risks. Women who are pregnant, planning pregnancy, or breastfeeding should discuss alternatives with their healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies, and procurement teams worldwide, and will request trade or institutional credentials. The team then provides pricing, availability, shipping details (including any cold‑chain requirements), and assists with import documentation.

Naltrexone differs from opioid agonist therapies such as methadone or buprenorphine because it blocks opioid receptors rather than activating them. This antagonist approach eliminates opioid effects and reduces cravings without producing sedation, but requires patients to be opioid‑free before initiation to avoid precipitated withdrawal.

Naltrexone Walter Ritter should be stored at ambient temperature, below 25 °C. Keep the tablets in the original packaging, protect them from moisture and direct sunlight, and ensure the container is tightly closed to maintain product stability.

The medication is supplied as oral tablets and is taken by mouth with or without food, as directed by the prescriber. Patients should swallow the tablet whole and avoid crushing or chewing unless specifically instructed otherwise.

Serious risks include hepatotoxicity, severe depression, suicidal thoughts, and allergic reactions such as rash or anaphylaxis. Patients should be monitored regularly for liver function abnormalities and any signs of mood changes, and they should seek immediate medical attention if severe reactions occur.

Naltrexone is contraindicated in individuals with acute hepatitis, severe liver impairment, or those currently dependent on opioids who have not undergone detoxification. It should also be used with caution in patients with renal impairment and those taking medications that may interact significantly.